NFKB1, nuclear factor kappa B subunit 1, 4790

N. diseases: 551; N. variants: 52
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0033860
Disease: Psoriasis
Psoriasis
0.180 AlteredExpression disease BEFREE The decreased expression of the DEGs was accompanied by the downregulation of STAT1, EHF, FOSL1, STAT3, and NFKB1 and the upregulation of FOXC1 upon blocking interleukin 17 (IL-17) or tumor necrosis factor α signaling in psoriasis. 30825251 2019
CUI: C0033860
Disease: Psoriasis
Psoriasis
0.180 Biomarker disease BEFREE The imiquimod-induced psoriasis mouse model was employed to examine the role of NFKB1 in psoriasis via the assessment of psoriasis area and severity index (PASI), including erythema, thickness and scales. 29748001 2018
CUI: C0033860
Disease: Psoriasis
Psoriasis
0.180 GeneticVariation disease GWASCAT Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. 26974007 2016
CUI: C0033860
Disease: Psoriasis
Psoriasis
0.180 Biomarker disease BEFREE Rs1020760 was preferentially associated with family history of psoriasis, implying that NFKB1 might not only play important roles in the development of psoriasis, but might also contribute to the special phenotypes of this disease. 27346731 2016
CUI: C0033860
Disease: Psoriasis
Psoriasis
0.180 GeneticVariation disease BEFREE We confirmed four known psoriasis susceptibility loci (IL12B, IFIH1, ERAP1 and RNF114; 2.30 × 10(-20)≤P≤2.41 × 10(-7)) and identified three new susceptibility loci: 4q24 (NFKB1) at rs1020760 (P=2.19 × 10(-8)), 12p13.3 (CD27-LAG3) at rs758739 (P=4.08 × 10(-8)) and 17q12 (IKZF3) at rs10852936 (P=1.96 × 10(-8)). 25006012 2014
CUI: C0033860
Disease: Psoriasis
Psoriasis
0.180 Biomarker disease BEFREE In addition, the regulation network between transcription factors and pathways revealed that NF-κB1 could promote the Toll-like receptor signaling pathway and that SP3 may inhibit the steroid hormone biosynthesis pathway in psoriasis. 23078099 2013
CUI: C0033860
Disease: Psoriasis
Psoriasis
0.180 GeneticVariation disease LHGDN Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. 19169254 2009
CUI: C0033860
Disease: Psoriasis
Psoriasis
0.180 Biomarker disease BEFREE Our study supported the involvement of six candidate genes in susceptibility to psoriasis: SCL12A8, which belongs to the solute carrier gene family; FLG and TGM5, which are involved in epidermal differentiation; CARD15 and CYLD, which modulate the transcription factor NF-kB; and IL1RN, which encodes an IL receptor antagonist. 19554025 2009
CUI: C0033860
Disease: Psoriasis
Psoriasis
0.180 GeneticVariation disease LHGDN Compared with the DD genotype, a significantly increased psoriasis risk was associated with the NFKB1 WW genotype (adjusted OR = 1.57, 95% CI = 1.10-2.24). 18330586 2008
CUI: C0033860
Disease: Psoriasis
Psoriasis
0.180 GeneticVariation disease BEFREE Compared with the DD genotype, a significantly increased psoriasis risk was associated with the NFKB1 WW genotype (adjusted OR = 1.57, 95% CI = 1.10-2.24). 18330586 2008